Aquapharm turns marine expertise to Alzheimer's research
This article was originally published in Scrip
Executive Summary
Aquapharm Biodiscovery, a Scottish marine biotech company, has entered a research agreement with Dundee University to develop new drugs based on marine products to target Alzheimer's disease.